Improving Access to Clinical Trials Act of 2009
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
(This measure has not been amended since it was introduced. The summary of that version is repeated here.)
Improving Access to Clinical Trials Act of 2009 - Amends title XVI (Supplemental Security Income) (SSI) of the Social Security Act (SSA) to exclude from income for SSI eligibility purposes any compensation in the amount of the first $2,000 per year received by an individual for participation in clinical trials involving research and testing of treatments for rare diseases or conditions.
Amends SSA title XIX (Medicaid) to make a similar exclusion from income of such compensation for the purposes of eligibility under the Medicaid program.
Directs the Comptroller General to study and report to Congress on the impact of this Act on enrollment of individuals who receive SSI benefits in clinical trials for rare diseases or conditions.
Became Public Law No: 111-255.
- Engrossed in Senate Formatted Text PDF Formatted XML
- Enrolled Bill Formatted Text PDF Formatted XML
- Introduced in Senate Formatted Text PDF Formatted XML
- Public Law Formatted Text PDF
Cite this page
U.S. Congress. (2026). S. 1674: Improving Access to Clinical Trials Act of 2009. 111th Congress. Open America. https://openamerica.io/bill/111-S-1674/
"S. 1674: Improving Access to Clinical Trials Act of 2009." 111th Congress, 2026, Open America, https://openamerica.io/bill/111-S-1674/.
S. 1674, 111th Cong. (2026), https://openamerica.io/bill/111-S-1674/.
[S. 1674: Improving Access to Clinical Trials Act of 2009](https://openamerica.io/bill/111-S-1674/)